bpc-157 fda warning 2025 An advisory panel narrowly voted to ease restrictions on injectable “wellness” peptides like and TB-500, despite FDA scientists there's little evidence they're safe or effective. If the FDA follows FDA Panel Endorses Lifting Restrictions

It is primarily investigated for its oxytocic properties , enhanced half-life, and interaction with G-protein coupled receptors in smooth muscle models

Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use

J Antimicrob Chemother

Important Notice: This product is intended solely for laboratory research and development purposes